Angiogenesis	0	12	O
in	13	15	O
the	16	19	O
caprine	20	27	B-Organism
caruncles	28	37	B-Organism_subdivision
in	38	40	O
non	41	44	O
-	44	45	O
pregnant	45	53	O
and	54	57	O
pregnant	58	66	O
normal	67	73	O
and	74	77	O
swainsonine	78	89	B-Drug_or_compound
-	89	90	O
treated	90	97	O
does	98	102	B-Organism
.	102	103	O

Microvascular	105	118	O
corrosion	119	128	O
casts	129	134	O
of	135	137	O
caruncles	138	147	B-Organism_subdivision
from	148	152	O
non	153	156	O
-	156	157	O
pregnant	157	165	O
and	166	169	O
pregnant	170	178	O
doe	179	182	O
goats	183	188	B-Organism
at	189	191	O
4	192	193	O
,	193	194	O
7	195	196	O
,	196	197	O
10	198	200	O
,	200	201	O
13	202	204	O
,	204	205	O
16	206	208	O
,	208	209	O
and	210	213	O
18	214	216	O
weeks	217	222	O
were	223	227	O
examined	228	236	O
with	237	241	O
scanning	242	250	O
electron	251	259	O
microscopy	260	270	O
.	270	271	O

The	272	275	O
internal	276	284	O
convex	285	291	O
surface	292	299	O
of	300	302	O
the	303	306	O
caruncles	307	316	B-Organism_subdivision
of	317	319	O
non	320	323	O
-	323	324	O
pregnant	324	332	O
does	333	337	B-Organism
was	338	341	O
covered	342	349	O
with	350	354	O
capillary	355	364	B-Multi-tissue_structure
meshes	365	371	I-Multi-tissue_structure
of	372	374	O
regular	375	382	O
diameter	383	391	O
and	392	395	O
form	396	400	O
,	400	401	O
without	402	409	O
crypts	410	416	O
.	416	417	O

As	418	420	O
pregnancy	421	430	O
advanced	431	439	O
the	440	443	O
complexity	444	454	O
of	455	457	O
the	458	461	O
vasculature	462	473	B-Multi-tissue_structure
increased	474	483	O
:	483	484	O
at	485	487	O
4	488	489	O
weeks	490	495	O
the	496	499	O
surface	500	507	O
showed	508	514	O
a	515	516	O
pattern	517	524	O
of	525	527	O
ridges	528	534	O
separated	535	544	O
by	545	547	O
troughs	548	555	O
.	555	556	O

At	557	559	O
later	560	565	O
stages	566	572	O
,	572	573	O
branches	574	582	O
of	583	585	O
radial	586	592	B-Multi-tissue_structure
arteries	593	601	I-Multi-tissue_structure
penetrated	602	612	O
the	613	616	O
periphery	617	626	O
forming	627	634	O
an	635	637	O
extensive	638	647	O
mesh	648	652	O
of	653	655	O
capillaries	656	667	B-Tissue
on	668	670	O
the	671	674	O
concave	675	682	O
surface	683	690	O
.	690	691	O

Capillary	692	701	B-Tissue
diameters	702	711	O
increased	712	721	O
significantly	722	735	O
during	736	742	O
pregnancy	743	752	O
,	752	753	O
especially	754	764	O
after	765	770	O
4	771	772	O
weeks	773	778	O
,	778	779	O
when	780	784	O
large	785	790	O
flattened	791	800	O
sinusoids	801	810	O
formed	811	817	O
.	817	818	O

These	819	824	O
sinusoids	825	834	O
had	835	838	O
a	839	840	O
great	841	846	O
deal	847	851	O
of	852	854	O
surface	855	862	O
area	863	867	O
for	868	871	O
potential	872	881	O
contact	882	889	O
with	890	894	O
the	895	898	O
fetal	899	904	O
component	905	914	O
.	914	915	O

The	916	919	O
caprine	920	927	B-Organism
placenta	928	936	B-Organ
is	937	939	O
usually	940	947	O
considered	948	958	O
to	959	961	O
have	962	966	O
increased	967	976	O
interhemal	977	987	O
distance	988	996	O
compared	997	1005	O
with	1006	1010	O
endotheliochorial	1011	1028	O
and	1029	1032	O
hemochorial	1033	1044	O
types	1045	1050	O
:	1050	1051	O
our	1052	1055	O
results	1056	1063	O
suggest	1064	1071	O
that	1072	1076	O
the	1077	1080	O
very	1081	1085	O
extensive	1086	1095	O
development	1096	1107	O
of	1108	1110	O
sinusoids	1111	1120	B-Tissue
and	1121	1124	O
crypts	1125	1131	O
may	1132	1135	O
compensate	1136	1146	O
for	1147	1150	O
any	1151	1154	O
negative	1155	1163	O
consequences	1164	1176	O
of	1177	1179	O
the	1180	1183	O
placental	1184	1193	B-Organ
architecture	1194	1206	O
.	1206	1207	O

Placental	1208	1217	B-Organ
angiogenesis	1218	1230	O
,	1230	1231	O
which	1232	1237	O
is	1238	1240	O
physiologically	1241	1256	O
normal	1257	1263	O
,	1263	1264	O
may	1265	1268	O
serve	1269	1274	O
as	1275	1277	O
a	1278	1279	O
general	1280	1287	O
model	1288	1293	O
of	1294	1296	O
this	1297	1301	O
process	1302	1309	O
in	1310	1312	O
other	1313	1318	O
circumstances	1319	1332	O
,	1332	1333	O
such	1334	1338	O
as	1339	1341	O
tumor	1342	1347	B-Pathological_formation
.	1347	1348	O

The	1349	1352	O
effect	1353	1359	O
of	1360	1362	O
swainsonine	1363	1374	B-Drug_or_compound
(	1375	1376	O
active	1376	1382	O
compound	1383	1391	O
of	1392	1394	O
locoweed	1395	1403	B-Organism
and	1404	1407	O
a	1408	1409	O
potential	1410	1419	O
anticancer	1420	1430	O
drug	1431	1435	O
)	1435	1436	O
on	1437	1439	O
vascular	1440	1448	B-Multi-tissue_structure
development	1449	1460	O
showed	1461	1467	O
no	1468	1470	O
differences	1471	1482	O
in	1483	1485	O
sinusoidal	1486	1496	O
diameters	1497	1506	O
at	1507	1509	O
7	1510	1511	O
weeks	1512	1517	O
,	1517	1518	O
but	1519	1522	O
a	1523	1524	O
decrease	1525	1533	O
in	1534	1536	O
capillary	1537	1546	B-Tissue
density	1547	1554	O
was	1555	1558	O
noted	1559	1564	O
.	1564	1565	O

Swainsonine	1566	1577	B-Drug_or_compound
caused	1578	1584	O
a	1585	1586	O
great	1587	1592	O
distortion	1593	1603	O
to	1604	1606	O
the	1607	1610	O
vasculature	1611	1622	B-Multi-tissue_structure
at	1623	1625	O
18	1626	1628	O
weeks	1629	1634	O
.	1634	1635	O

The	1636	1639	O
effects	1640	1647	O
of	1648	1650	O
this	1651	1655	O
compound	1656	1664	O
on	1665	1667	O
the	1668	1671	O
vascular	1672	1680	B-Multi-tissue_structure
development	1681	1692	O
lend	1693	1697	O
credibility	1698	1709	O
to	1710	1712	O
its	1713	1716	O
potential	1717	1726	O
as	1727	1729	O
an	1730	1732	O
anticancer	1733	1743	O
agent	1744	1749	O
.	1749	1750	O

